119 related articles for article (PubMed ID: 27263666)
1. Non-viral liver disease burden in HIV-monoinfected individuals: a longitudinal observational retrospective cohort study.
Shur NF; Tan Y; Goubet S; Fisher M; Gilleece Y; Verma S
AIDS Care; 2016 Dec; 28(12):1522-1527. PubMed ID: 27263666
[TBL] [Abstract][Full Text] [Related]
2. Chronic liver disease in central Harlem: the role of alcohol and viral hepatitis.
Frieden TR; Ozick L; McCord C; Nainan OV; Workman S; Comer G; Lee TP; Byun KS; Patel D; Henning KJ
Hepatology; 1999 Mar; 29(3):883-8. PubMed ID: 10051493
[TBL] [Abstract][Full Text] [Related]
3. Elevated alanine aminotransferase levels in HIV-infected persons without hepatitis B or C virus coinfection.
Alghamdi S; Alrbiaan A; Alaraj A; Alhuraiji A; Alghamdi M; Alrajhi A
Ann Saudi Med; 2016; 36(4):288-91. PubMed ID: 27478915
[TBL] [Abstract][Full Text] [Related]
4. Nonviral Liver Disease Burden in People Living With HIV and Elevated Transaminases: A Cross-Sectional Study.
Katarey D; Tan Y; Mourad A; Potts JR; Vickers L; Beksinska A; Sharp H; Parnell B; Gilleece Y; Verma S
J Acquir Immune Defic Syndr; 2024 Jan; 95(1):97-106. PubMed ID: 37831608
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients.
Vuille-Lessard É; Lebouché B; Lennox L; Routy JP; Costiniuk CT; Pexos C; Giannakis A; Szabo J; Klein MB; Sebastiani G
AIDS; 2016 Nov; 30(17):2635-2643. PubMed ID: 27603289
[TBL] [Abstract][Full Text] [Related]
6. Liver fibrosis in patients with chronic hepatitis C and persistently normal liver enzymes: influence of HIV infection.
Martin-Carbonero L; de Ledinghen V; Moreno A; Maida I; Foucher J; Barreiro P; Romero M; Satta G; Garcia-Samaniego J; Gonzalez-Lahoz J; Soriano V
J Viral Hepat; 2009 Nov; 16(11):790-5. PubMed ID: 19413693
[TBL] [Abstract][Full Text] [Related]
7. Severe liver disease associated with prolonged exposure to antiretroviral drugs.
Maida I; Núñez M; Ríos MJ; Martín-Carbonero L; Sotgiu G; Toro C; Rivas P; Barreiro P; Mura MS; Babudieri S; Garcia-Samaniego J; González-Lahoz J; Soriano V
J Acquir Immune Defic Syndr; 2006 Jun; 42(2):177-82. PubMed ID: 16688096
[TBL] [Abstract][Full Text] [Related]
8. Incidence and risk factors for chronic elevation of alanine aminotransferase levels in HIV-infected persons without hepatitis b or c virus co-infection.
Kovari H; Ledergerber B; Battegay M; Rauch A; Hirschel B; Foguena AK; Vernazza P; Bernasconi E; Mueller NJ; Weber R
Clin Infect Dis; 2010 Feb; 50(4):502-11. PubMed ID: 20085465
[TBL] [Abstract][Full Text] [Related]
9. Liver biopsy findings for HIV-infected patients with chronic hepatitis C and persistently normal levels of alanine aminotransferase.
Sánchez-Conde M; Berenguer J; Miralles P; Alvarez F; Carlos Lopez J; Cosin J; Pilar C; Ramirez M; Gutierrez I; Alvarez E
Clin Infect Dis; 2006 Sep; 43(5):640-4. PubMed ID: 16886160
[TBL] [Abstract][Full Text] [Related]
10. Clinical characteristics of hepatitis B and C virus infections in HIV-infected patients.
Phuangchoei P; Chotiyaputta W; Chayakulkeeree M
J Med Assoc Thai; 2015 Mar; 98(3):226-31. PubMed ID: 25920291
[TBL] [Abstract][Full Text] [Related]
11. Association between elevated coffee consumption and daily chocolate intake with normal liver enzymes in HIV-HCV infected individuals: results from the ANRS CO13 HEPAVIH cohort study.
Carrieri MP; Lions C; Sogni P; Winnock M; Roux P; Mora M; Bonnard P; Salmon D; Dabis F; Spire B;
J Hepatol; 2014 Jan; 60(1):46-53. PubMed ID: 23978720
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic fatty liver disease and hepatic fibrosis among perinatally HIV-monoinfected Asian adolescents receiving antiretroviral therapy.
Sudjaritruk T; Bunupuradah T; Aurpibul L; Kosalaraksa P; Kurniati N; Sophonphan J; Trinavarat P; Visrutaratna P; Srinakarin J; Chaijitraruch N; Puthanakit T;
PLoS One; 2019; 14(12):e0226375. PubMed ID: 31856189
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis B e antigen-positive and high levels of alanine aminotransferase are associated with prevalence of metabolic syndrome in chronic HBV patients.
Ha M; Xia W; Tang D; Wu J; Sun L; Shen W; Huang Z; Chen X; Shan W
Obes Res Clin Pract; 2016; 10(6):673-679. PubMed ID: 26515918
[TBL] [Abstract][Full Text] [Related]
14. Predictors of liver fibrosis in HIV-infected patients with chronic hepatitis C virus (HCV) infection: assessment using transient elastometry and the role of HCV genotype 3.
Barreiro P; Martín-Carbonero L; Núñez M; Rivas P; Morente A; Simarro N; Labarga P; González-Lahoz J; Soriano V
Clin Infect Dis; 2006 Apr; 42(7):1032-9. PubMed ID: 16511772
[TBL] [Abstract][Full Text] [Related]
15. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
[TBL] [Abstract][Full Text] [Related]
16. NIH consensus development statement on management of hepatitis B.
Belongia EA; Costa J; Gareen IF; Grem JL; Inadomi JM; Kern ER; McHugh JA; Petersen GM; Rein MF; Sorrell MF; Strader DB; Trotter HT
NIH Consens State Sci Statements; 2008 Oct 22-24; 25(2):1-29. PubMed ID: 18949020
[TBL] [Abstract][Full Text] [Related]
17. Persistently normal alanine aminotransferase levels in HIV/HCV-coinfected patients: the role of steatosis.
Bani-Sadr F; Barange K; Daoud F; Jacomet C; Bicart-See A; Rosenthal E; Cacoub P; Pol S; Perronne C; Carrat F;
HIV Med; 2009 Aug; 10(7):417-21. PubMed ID: 19490173
[TBL] [Abstract][Full Text] [Related]
18. Combined effects of chronic hepatitis virus infections and substance-use habits on chronic liver diseases in Taiwanese aborigines.
Lin HH; Wang LY; Shaw CK; Cheng ML; Chung WK; Chiang HJ; Lin TY; Chen CJ
J Formos Med Assoc; 2002 Dec; 101(12):826-34. PubMed ID: 12632815
[TBL] [Abstract][Full Text] [Related]
19. Influence of viral chronic hepatitis co-infection on plasma drug concentrations and liver transaminase elevations upon therapy switch in HIV-positive patients.
Torti C; Lapadula G; Uccelli MC; Quiros-Roldan E; Regazzi M; Ladisa N; Micheli V; Orani A; Patroni A; Caputo SL; Tirelli V; Di Giambenedetto S; Cologni G; Costarelli S; Gargiulo F; Manca N; Carosi G;
Int J Antimicrob Agents; 2007 Feb; 29(2):185-90. PubMed ID: 17011754
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of hepatitis B and C viruses and risk factors in HIV infected children at the Felgehiwot referral hospital, Ethiopia.
Abera B; Zenebe Y; Mulu W; Kibret M; Kahsu G
BMC Res Notes; 2014 Nov; 7():838. PubMed ID: 25421947
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
